23.7 C
New York
Tuesday, June 2, 2026

Tag: Objective

Cielo Waste Solutions to Present Project Nahoonai at ICAO Aviation Climate Week 2026

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VEON Closes USD 1.4 Billion Bond Offering, Refinancing 2027 Notes Ahead of Schedule

Dubai and New York, June 2, 2026 – VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), today announces the successful closing of a USD 1.4 billion dual-tranche senior unsecured notes offering (the “Offering”) by its subsidiary VEON Midco B.V. (the “Issuer”). The Offering refinances substantially all of VEON’s debt maturing in 2027 ahead of schedule and reflects sustained confidence in VEON’s digital operator transformation and AI1440 strategy.

/C O R R E C T I O N — Ranok Therapeutics/

In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic...

Cellhub Debuts Cutting-Edge “Connected Grocery” Programs at ROFDA and FMI GroceryLab Events

Connectivity provider and Premier T-Mobile Agent Cellhub launches “Connected Grocery” 5G advanced plans for grocery retailers.

Hammond Power Solutions Declares Quarterly Dividend

GUELPH, Ontario, May 29, 2026 (GLOBE NEWSWIRE) -- (TSX: HPS.A) The Board of Directors of Hammond Power Solutions Inc. (“HPS”) declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class A Subordinate Voting Share of HPS and a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class B Common Share of HPS payable on June 17, 2026, to shareholders of record at the close of business on June 10, 2026. The ex-dividend date is June 10, 2026.

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.

HeartSciences Announces Conference Participation and Investor Webinar

Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85

LanzaTech Announces Reverse Stock Split as Part of Nasdaq Compliance Plan

CHICAGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (“LanzaTech” or the “Company”) (NASDAQ: LNZA), a leading carbon capture and transformation company, today announced that it will implement a 1-for-100 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock (the “Common Stock”), effective August 18, 2025 at 5:00 p.m. Eastern Time. Immediately prior to effecting the Reverse Stock Split, LanzaTech will decrease the par value of the Common Stock from $0.0001 to $0.0000001 per share (the “Par Value Change”) and increase the number of authorized shares of Common Stock from 600,000,000 to 2,580,000,000 (the “Authorized Share Increase”). At the effective time of the Reverse Stock Split, the number of authorized shares of Common Stock will be proportionately decreased to 25,800,000. The Reverse Stock Split, Par Value Change, and Authorized Share Increase were approved by stockholders at LanzaTech's 2025 Annual Meeting of Stockholders held on July 28, 2025.

Blue Sky Uranium Closes 3rd and Final Tranche of Non-Brokered Private Placement

/NOT FOR DISTRIBUTION TO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSX Venture Exchange: BSKFrankfurt Stock Exchange: MAL2OTCQB Venture Market (OTC): BKUCF VANCOUVER, BC, Aug. 15,...

OTC Markets Group Welcomes MÉLIUZ S.A. to OTCQX

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced MÉLIUZ S.A. (OTCQX: MLIZY), the first Bitcoin Treasury Company in Brazil and Latin America fully dedicated to accretively growing its Bitcoin holdings for shareholders while consistently delivering a positive Bitcoin Yield. While pursuing this strategic objective, the Company also operates a robust technology-driven platform that accelerates sales by generating qualified traffic for partner stores and brands, empowering users through an easy and integrated shopping journey enriched with financial services, has qualified to trade on the OTCQX® Best Market.

XPENG and the Volkswagen Group Announce Entry into Agreement on Expanding E/E Architecture Technical Collaboration

XPENG and the Volkswagen Group Announce Entry into Agreement on Expanding E/E Architecture Technical Collaboration

Scripps wins five National Murrow Awards

CINCINNATI, Aug. 14, 2025 /PRNewswire/ -- Scripps News and four local television stations owned by The E.W. Scripps Company (NASDAQ: SSP) have earned prestigious 2025...

Quantum Computing Inc. Reports Second Quarter 2025 Financial Results

HOBOKEN, N.J., Aug. 14, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today...

Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 14, 2025 /PRNewswire/ -- Equity Insider News Commentary – Despite alarming federal budget cuts...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsObjective